C4 Therapeutics to Participate in Upcoming September Investor Conferences

About this update from C4 Therapeutics, Inc.

WATERTOWN, Mass. , Aug. 29, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor conferences. Fireside Chat Details: Event: Wells Fargo Healthcare Conference taking place in Boston, MA Date/Time: September 5, 2024 at 8:45 AM ET Event: 2024 Cantor Global Healthcare Conference taking place in New York, New York Date/Time: September 18, 2024 at 8:35 AM ET Live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com . Archived replays of the webcasts will be available for approximately 30 days following the live events. About C4 Therapeutics C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com . Contacts: Investors: Courtney Solberg Senior Manager, Investor Relations [email protected] Media: Loraine Spreen Senior Director, Corporate Communications & Patient Advocacy [email protected] Source: C4 Therapeutics, Inc.

View stock analysis, news, and events for C4 Therapeutics, Inc.